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1. Introduction 
The cardiac surgical procedures are increasingly performed each year up to a number >700000 
(data in 1997 in US) per year, of which >600000 are coronary artery bypass grafting (CABG) 
procedures. After 1997, there has been a gradual decrease in CABG procedures as 
percutaneous coronary interventions (PCI) grow. In 2005, a total of 699000 cardiac surgical 
procedures were reported, including 469000 surgical coronary revascularization procedures. It 
is still debated whether CABG procedures will continue to decrease as relative benefits of PCI 
continue to be evaluated. As the number of aging population increases and risk factors 
(e.g.,obesity and diabetes) occur, cardiovascular diseases are also estimated to increase; 
however, it is not clear that changes in life style or advancing medical management will reduce 
the prevalance and incidence of these diseases. Although the cardiac surgery is not the 
primary solution, CABG procedures are still the most commonly performed cardiac 
procedures and it will remain one of the management options (Thys,2009;London et al,2008). 
There is an explosive growth in these procedures due to improvements in operative 
outcomes, inclusion of older and sicker patients for cardiac surgeries and expansion of these 
surgeries to community hospitals. However, although the physicians develop greater 
confidence and capacity to perform the procedures, the morbidity, mortality and resource 
utilization are still higher in the elderly population; especially in octagenarians. Scott et al. 
(2005) reported longer intensive care unit (ICU) and hospital stay with higher rates of 
postoperative renal failure and neurologic complications; and Baskett et al. (2005) reported 
more death and stroke after CABG in octagenarians. As the cardiac surgical procedures 
grow with an aging population with increased mortality and morbidity, more 
anesthesiologists become specialized in cardiovascular anesthesiology, practicing cardiac 
anesthesia excusively in active cardiac surgical centers; changing their focus from anesthetic 
management of patients with cardiovascular diseases to cardiovascular medicine; medical 
and surgical management of cardiovascular patients (Thys,2009). 
2. Anesthetic management 
The primary goal of cardiac surgery is not just a minimally acceptable outcome where the 
patient survives without life-threatenening complications or persistent clinically manifest 
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organ dysfunctions or simply hospital survival; but a healthy, productive long-term 
survivor (Murphy et al,2009). 
Anesthetic protocols in cardiac surgery are investigated and analized in terms of their effect 
on postoperative mortality and incidence of myocardial infarction following cardiac 
surgery, postoperative cardiac troponin release, need for inotropic support, time on 
mechanical ventilation, ICU and hospital stay (Landoni et al,2009). 
2.1 Preoperative evaluation and premedication 
In order to reduce the fear and anxiety of the patient, provide analgesia for painful 
interventions such as vascular cannulation before anesthetic induction and to provide 
amnesia to some degree, pharmacological interventions are used. These agents are also 
supposed to prevent the anginal episodes which are clinically silent preoperatively. Oral, 
intravenous or intramuscular benzodiazepines are the agents that are most frequently 
chosen (London et al,2008). Agents and their dosages to be selected depend on the patients’ 
age and physiologic status. High doses are desirable for the patients with coronary artery 
disease, whereas low doses are more appropriate for patients with valvular diseases whose 
physiologic status is compansated with enhanced sympathetic tone (Liu et al,2004). 
However, on arrival to the operating room the patients may receive further medications in 
case of an inadequate sedation, prior to the interventions that are planned before the 
induction. The beneficial effects of premedication should also be secured by the proper 
conditions of the operating room including the temperature and also the verbal interaction 
with the patient (London et al,2008).  
Most popular premedicants 
For anxiolysis and amnesia; 
 Diazepam oral: 0.1-0.15 mg/kg 
 Midazolam intravenous: 1-2 mg 
For analgesia; 
 Morphine intramuscular: 0.1-0.15 mg/kg 
 Fentanyl intravenous: 50-75 µg 
The anesthetist has an important role in preoperative administration of cardiovascular 
medications especially the anti-anginal medications, ensuring that these agents are ordered 
for morning with sips of water, as the cardiac anesthesiologist is becoming a ‘perioperative 
physician’ (London et al,2008). 
2.2 Monitoring 
On arrival to the operating room, before induction of anesthesia, preoxygenation, 
monitoring with pulse oximetry, ECG, non-invasive BP and radial artery cannulation for 
ABP, ECG and also for the high-risk patients central venous catheters and pulmonary artery 
catheter should be in place (Reich et al,2008). 
2.2.1 Electrocardiogram (ECG) 
A multi-lead ECG system with a continuous paper writeout and online ST-segment trending 
system is useful in early diagnosis of myocardial ischemia and detecting arrhythmias. Also a 
preinduction rhythm strip or frozen on the monitor screen may help to assess the changes 
intraoperatively (Morgan et al,2002). An angiographically identified areas that are at risk for 
transmural ischemia can be observed more sensitively by specific placement of the leads 
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(Reich et al,2008). The electrocoutery may interfere with ECG recordings resulting in 
difficulty in dysrhythmia analysis in the operating room (Morgan et al,2002). 
2.2.2 Arterial blood pressure monitoring (ABP) 
The radial artery is used for the CABG procedures to monitor the blood pressure. The 
cannulation is applied before anesthetic induction in order to observe the hemodynamic 
response closely (Reich et al,2008). Radial artery cannulation requires the testing of the 
competancy of ulnar collateral circulation of the hand in case of radial artery thrombosis. 
This test is the Allen test; however it is not completely reliable. Some centers prefer the non-
dominant side for cannulation and some other prefer to use the side opposite to the 
proposed internal mammarian artery dissection to avoid inaccurate measurements caused 
by the sternal retractors tenting the subclavian artery. Furthermore, after the period of 
hypothermia there can be alterations in the measurements from radial artery (lower than 
aortic pressure with a gradient 10-30 mmHg) which is mainly caused by decreased vascular 
resistance. Temporarily measuring blood pressure directly from the aorta via a needle or 
cardioplegia cannula can be an acceptable approach (Morgan et al,2002). 
2.2.3 Central venous cannulation 
Cardiac surgery is associated with large fluid shifts and need for multiple drug infusions 
(Morgan et al,2002). In order to measure pressure to regulate volume infusion and for both 
volume and vasoactive drug administration, central venous catheterization (CVC) has 
become a routine practice (London et al,2008). CVC is used for measuring the right ventricle 
(RV) filling pressures giving an estimate for intravascular volume status and RV function. 
For accurate measurement of the pressures, the catheter tip should be in one of the large 
thoracic veins or the right atrium. With a short and straight course to the right atrium (RA) 
assuring RA or superior venous cava (SVC) localization of the catheter tip, internal jugular 
vein is preferred for the site of this central catheterization (Reich et al,2008). 
Following serial measurements to observe the trends is more reliable and safe when 
compared to individual numbers. Central venous pressure (CVP) is not a direct indicator of 
left heart filling pressure, but it may provide an estimate for these pressures in patients with 
good LV function. The catheter can also be used for both indicating the RA pressures and 
cerebral venous pressure if the tip is in SVC. The increase in CVP may result in a decrease in 
cerebral perfusion pressure. Occasionally this may be caused by a malposition of the 
catheter during CPB, which is to be corrected immediately by the surgeon to avoid cerebral 
edema and poor cerebral perfusion (Reich et al,2008). 
CVC may be applied before induction using sedation including small doses of midazolam 
and fentanyl supplemented by oxygen via a face mask avioiding hypoxia, or after induction 
of anesthesia. Multi-lumen catheters allow for both fluid administration and drug infusions 
at the same time (Morgan et al,2002). 
2.2.4 Pulmonary artery catheterization (PAC) 
The PAC providing various physiologic information has been shown to have little effect on 
clinical outcome, leading to a lower use currently; decreased 60-80% over the past decade. 
Although the criteria to use PAC have not been demonstrated clearly, it is recommended to 
be reserved for high-risk patients, as the patients with multi-system dysfunction are 
increasingly scheduled for cardiac surgical procedures (Reich et al,2008). 
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High-risk patients requiring PAC  (Reich et al,2008) 
1. Significant impairment of ventricular function 
 EF<40% 
 Acute or Chronic congestive heart failure 
 Elevation of left ventricular end-diastolic pressure (LVEDP) on preoperative 
catheterization 
 Need for preoperative intraaortic balon pump (IABP) 
 Acute or chronic severe mitral regurgitation due to ischemia 
 Ventricular septal defect after myocardial infarction 
 Other mechanical complications 
2. High-risk for intraoperative ischemia or difficult revascularization 
 Recent, large myocardial infarction 
 Severe unstable angina 
 Known poor revascularization targets or severe microcirculatory disease 
 Reoperation 
 Catheterization laboratory PCI ‘crash’ 
3. Severe co-morbidities 
 Renal failure (need for dialysis) 
 Severe chronic obstructive pulmonary disease 
4. Combined procedures that prolonges the duration of surgery or add significant blood 
loss (CABG-carotid, other vascular procedures) 
PAC provides detailed information with various parameters such as PCWP, PA diastolic 
pressure and derived parameters, estimating the left ventricular filling pressures-preload 
more precisely than CVC (Reich et al,2008;Morgan et al,2002). However, there are some 
limiting factors altering the accuracy of these measurements such as mitral stenosis, LA 
myxoma, pulmonary venous obstruction, elevated alveolar pressure, decreased left 
ventricular compliance and aortic insufficiency; which are to be considered during the 
anesthetic management (Reich et al,2008). 
2.2.5 Transesophageal echocardiography 
One of the earliest signs of acute myocardial ischemia is diastolic dysfunction followed by 
systolic segmental wall motion abnormalities which occurs within seconds after acute 
coronary occlusion. Coronary artery disease is associated with segmental wall motion 
abnormalities more than ECG changes. However, these wall motion abnormalities are not 
specific for myocardial ischemia; that they may occur during CABG procedure due to 
loading conditions altering pre- and afterload, transient motion abnormalities caused by 
myocardial stunning during the ischemic periods of weaning from CPB and also inotropic 
agents or elevated catecholamine levels. TEE is recommended for high-risk patients for 
myocardial ischemia with a category II indication (TEE may be helpful in improving clinical 
outcomes) by ASA. This indication is strenghtened when ECG cannot be used for detection of 
ischemia in situations such as the existence of LBBB, extensive Q waves or ST-T segment 
changes on baseline ECG. However, it is weakened when there are wall motion 
abnormalities due to fibrotic, calcified or aneurysmal myocardium at the baseline (London 
et al,2008). 
Category I indications (TEE is useful in improving clinical outcomes) for the usage of TEE 
includes, suspected thoracal aortic aneurysm-dissection or disruption in unstable patients 
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in the preoperative period; life-threatening hemodynamic disturbance, valve repair, 
congenital heart surgery, hypertrophic obstructive cardiomyopathy repair, endocarditis, 
aortic valve function in aortic dissection repair, evaluation of pericardial window 
procedures intraoperatively and unexplained hemodynamic disturbances in ICU setting. 
Category II (TEE may be helpful in improving clinical outcomes) indications include 
hemodynamic disturbances, cardiac aneurysm repair, tumour excision, air emboli, 
intracardiac embolectomy, aortic dissection repair, pericardial surgery and also increased 
risk of myocardial ischemia. Category III (TEE is infrequently useful in improving outcomes) 
indications include evaluation of myocardial perfusion, coronary artery anatomy, graft 
patency, repair of non-HOCMs, endocarditis in non-cardiac surgery, monitoring emboli in 
orthopedic surgeries, repair of thoracic aortic injuries, uncomplicated pericarditis, 
pleuropulmonary disease, monitoring cardioplegia administration and also placement of 
IABP, ICD or PA catheters (Roscoe,2007). 
2.3 Anesthetic induction 
Anesthetic induction of cardiac surgical patients requires titration of drugs in order to 
avoid any increase in oxygen consumption and decrease in oxygen supply. Titration of 
induction agents with monitoring of the hemodynamics is more important than the type 
of the drug chosen (Barnes,2002a). During induction hypertension and tachycardia in 
patients with normal ventricular function, hypertension and LV hypertrophy should be 
avoided as well as hypotension and myocardial depression in patients with depressed 
ventricular function or stenoses. These agents should also provide smooth intubating 
conditions for those patients. These major concerns of cardiac anesthetic practice can be 
managed by using small doses of vasopressors for hypotension and by deepening 
anesthesia or administering ǃ-blockers for the hyperdynamic responses. In terms of 
intraoperative ischemia, postoperative myocardial infarction or death, there is no single 
technique superior to others (London et al,2008).  
The choice of the anesthetic method depends mainly on left ventricular (LV) function and 
whether the patient is suitable for early extubation or not. LV function determines the 
dosages of the anesthetic agents depending on the hemodynamic response of the patient. 
Early extubation is a desired method in order to reduce the postoperative need for 
mechanical ventilation resulting in shorter periods of ICU stay, decreasing the cost. There is 
no single strategy to be recommended for all cardiac surgical patients; hypnotics, opioids 
and volatile anesthetics are used in different combinations for both the induction and 
maintenance of anesthesia (London et al,2008). 
2.3.1 Thiopental 
Thiopental is the sulphur analogue of the oxybarbiturate pentobarbitone. It is used 3-7 
mg/kg intravenously for the induction of anesthesia, rapidly entering the CNS and 
producing unconsciousness within 30 seconds (Peck,2006; Stoelting&Hillier,2006). The dose 
that is required for induction depends on patients’ age (decreasing with age), weight and 
cardiac output (Stoelting&Hillier,2006). At sufficient plasma concentrations which is most 
easily maintained by continuous infusion, thiopental  produces an isoelectric EEG, 
contributing to a maximal reduction of cerebral oxygen requirements. At these 
concentrations inotropic support may be required to maintain adequate cerebral perfusion 
(Peck,2006). However, thiopental is seldom used as infusion, because of its long context-
sensitive half-time leading to a prolonged recovery period (Stoelting&Hillier,2006).  
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Thiopental causes a dose-dependent reduction in cardiac output, stroke volume and 
systemic vascular resistance associated with a compansatory tachycardia. At a dose of 5 
mg/kg intravenous thiopental causes a transient 10-20 mmHg decrease in blood pressure 
with a compansatory 15-20 bpm increase in heart rate. A decrease in myocardial 
contractility may occur, however it has been shown to be a less reduction when it is 
compared to volatile anesthetics (Stoelting&Hillier,2006).  
Along with the induction of anesthesia with barbiturates mild and transient reduction in 
systemic blood pressure occurs, which mainly depends on the peripheral vasodilation, 
depression of the medullary vasomotor center and decreased sympathetic outflow. These 
minimal alterations in blood pressure and cardiac output with barbiturate induction mainly 
depend on carotid sinus–mediated baroreceptor reflex responses offsetting the effects of 
vasodilation. This mechanism explains the vulnerability of the hypovolemic patients to the 
effects of barbiturate induction (Stoelting&Hillier,2006). 
The adverse effects including airway resistance, bronchospasm and postoperative nausea 
and vomiting, have led to a tendency towards the use of propofol, especially depending on 
its predictable pharmacokinetics and dynamics (London et al,2008). 
2.3.2 Propofol 
Propofol is an isopropylphenol (2,6 diisopropylphenol), replacing the barbiturates for 
induction, particularly for operations where rapid awakening is desirable, because of the 
complete awareness after propofol without any residual CNS effects 
(Peck,2006;Stoelting&Hillier,2006). The major advantage of using propofol as a part of the 
anesthetic protocol is the early extubation leading to reduced costs by shortening the LOS in 
ICU (D’Attelis et al,1997; Myeles et al,1997).  
In healthy adults the  induction dose of propofol is 1.5-2.5 mg/kg intravenous, with a 25-50 
% reduction to be used in elderly patients, with 2-6 µg/ml blood level producing 
unconsciousness depending on combined medications and age, and 1-1.5 µg/ml blood level 
resulting in awakening (Stoelting&Hillier,2006). 
Propofol decreases systemic blood pressure with corresponding changes in cardiac output 
and systemic vascular resistance. The blood pressure effects may be overt in hypovolemic 
patients, elderly patients and also patients with coronary artery disease compromising the 
left ventricle. Adequate hydration is often recommended to offset this effect of propofol. 
Unlike the effect of thiopental on blood pressure compansated by the increase in heart rate, 
propofol does not change heart rate. Furthermore, bradycardia and asystoli may also occur 
most probably because of the reduction in sympathetic outflow more than parasympathetic. 
It has been shown not to have any effect on sinoatrial or atrioventricular node in normal 
patients and patients with WPW syndrome allowing the usage of this drug for ablation 
procedures (Stoelting&Hillier,2006). 
2.3.3 Etomidate 
Etomidate is an imidazole derivative and an ester, which is used as an alternative to 
propofol and thiopental for induction of anesthesia, at a dose of 0.2-0.4 mg/kg 
intravenously, especially in patients with unstable hemodynamics, because of its least 
cardiovascular disturbance when compared to other agents (Peck,2006).  
After induction, involuntary myoclonic movements can occur, which can be attenuated by 
using opioids. Awakening after a single dose is more rapid than barbiturates, however 
duration of action prolongs with intermittently increased dosage or continuous infusion. 
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The main limiting factor of usage is the depression of adrenocortical function 
(Stoelting&Hillier,2006). 
The peripheral vascular resistance may fall slightly but there occurs no change in 
myocardial oxygen supply, contactility, stroke volume, cardiac output and blood pressure. 
In a dose-dependent manner, especially at the concentrations more than in clinical practice, 
etomidate may result in cardiac depression (Peck,2006;Stoelting&Hillier,2006). 
2.3.4 Ketamine 
Ketamine is a phencyclidine derivative, which results in a ‘dissociative anesthesia’ caused 
by the dissociation between thalamocortical and limbic systems. The dissociative anesthesia 
mimics a cataleptic state contributing to open eyes with slow nystagmic gaze; that 
wakefulness may appear to be present. Amnestic and analgesic properties are profound 
(Peck,2006;Stoelting&Hillier,2006).  
Unlike other induction agents, ketamine produces sympathetic nervous system stimulation 
with a rise in circulating levels of adrenalin and noradrenalin; increasing the heart rate, 
cardiac output, blood pressure and myocardial oxygen requirements (Peck,2006). These 
stimulating effects may be blunted by combination of ketamine with benzodiazepines or 
opioids or inhaled anesthetic agents (Stoelting&Hillier,2006). It does not seem to precipitate 
arrhythmias (Peck,2006). 
Induction doses of ketamine is 1-2 mg/kg intravenously and 2-4 mg/kg intramuscularly, 
allowing unconciousness within 30-60 seconds and 2-4 minutes, respectively. Awakening or 
return of consciousness occurs 10-20 minutes after induction, but full consciousness takes 
60-90 minutes. Intermittent doses or continuous infusions lead to prolonged emergence 
times (Stoelting&Hillier,2006). 
2.3.5 Midazolam 
Midazolam can be used for anesthetic induction with a dose of 0.1-0.2 mg/kg intravenously 
administered over 30-60 seconds. However, thiopental usually produces 50-100% faster 
induction when it is compared with midazolam, furthermore awakening from general 
anesthesia including midazolam induction has been shown to be 1-2.5 times longer than that 
of thiopental (Stoelting&Hillier,2006) (see also the maintenance of anesthesia). 
2.3.6 Neuromuscular blocking agents 
All of the available neuromuscular blocking agents (NMBA) have been used for cardiac 
surgical patients. Pancuronium offsetting the bradycardia effect of high-dose opioids has 
been the prefered NMBA, however it has also been shown to have potential to produce a 
tachycardia causing myocardial ischemia during induction. Rocuronium has been compared 
with pancuronium and reported to provide more adequate conditions especially for fast-
track anesthesia due to its less residual blockade and shorter time to extubation. 
Neuromuscular transmission monitoring is advised especially if fast-track anesthesia is 
planned (London et al,2008). 
2.4 The maintenance of anesthesia 
2.4.1 Intravenous anesthetic agents 
The anesthesia should be adequate in order to prevent ischemia during incision and 
sternotomy/sternal spreading; which are the periods of hyperstimulation. Anesthetic 
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dosages and the type of the drugs that are to be used depend on the desire of ‘fast-tracking’ 
the patient (Barnes,2002).  
High-dose opioid based anesthetic management of the cardiac surgical patients, with more 
stable hemodynamics providing a long-term mechanical ventilation ensuring the safety of 
the newly revascularized myocardium, was popular in cardiac anesthetic practice. 
However the growing interest in fast-track anesthesia and associated intraoperative 
awareness with high-dose opioid technique limited its usage (London et 
al,2008;Stoelting&Hillier,2006). As the sickest patients undergoing multi-vessel bypass 
grafting combined with valve-repair or replacement, repeat operations and other complex 
procedures such as ventricular septal defect repairs with CABG after acute myocardial 
infarction require a long duration of surgery, resulting in greater cumulative doses of 
anesthetic agents leading to a prolonged period of mechanical ventilation; the anesthetic 
management evolves into a plan including short-acting agents (e.g.sufentanil, propofol, 
remifentanil), avoiding agents with long half-lives (e.g.midazolam), depending mainly on 
volatile agents, identifying the adequate candidates and applying a‘wait and see’ technique 
for early extubation (London et al,2008). 
 Combinations of opioids with benzodiazepines especially low doses of midazolam, because 
of its ease of use, low cost, hemodynamic stability and postoperative amnesia effects, have 
been used in order to overcome the adverse effects (Stoelting&Hillier,2006). However, some 
investigators believe that the combination of midazolam and opioids should be abondoned 
as general anesthetics; because they believe that this combination only provides general 
amnesia (Vuylteke et al,1996;Russell et al,1993;Absolam et al,2000). Midazolam has been 
used in combination with propofol and/or inhaled anesthetics, as well as opioids 
(Stoelting&Hillier,2006;Barr et al,2000;Lehmann et al,2000;Barvais et al,2000).  
Remifentanil is a short-acting, esterase-metabolized without any active metabolites, rapid-
onset µ-opioid receptor agonist. It provides stable hemodynamics in high-risk cardiac 
surgical patients. Remifentanil-propofol combination has been proven to be safe with stable 
hemodynamics, delivering an adequate depth of anesthesia (Lehmann et al,2000). 
Sufentanil is a synthetic opioid, that has been used in combination with midazolam, 
propofol and inhaled anesthetics. Sufentanil combined with propofol has been shown to 
provide more stable hemodynamics when it is compared with fentanyl-based anesthetic 
protocols (Howie et al,1991). 
Propofol has already been used for maintenance of anesthesia in cardiac surgical patients 
with reduced left ventricular function or with low cardiac output states in combination with 
opioids such as fentanyl, remifentanil, sufentanil or alfentanil; providing stable 
hemodynamics at the recommended doses of 3-8 mg/kg/hour (Philips et al,1993;Sherry et 
al,1995;Bailey et al,1996). In combination with ketamine propofol provides more stable 
hemodynamics than its combination with fentanyl (Stoelting&Hillier,2006). 
2.4.2 Volatile anesthetic agents 
It was commonly believed that the choice of primary anesthetic agent in cardiac anesthesia 
does not lead to a different outcome (Tritapepe et al,2007).  In 1988, Warltier et al. (1988) 
reported that both halothane and isoflurane applied before ischemia improved left 
ventricular systolic function; in 1997 Cason et al.  first described the term anesthetic 
preconditioning, by showing protective effect of isoflurane applied shortly before ischemia. 
Since than numbers of experimental studies revealed the cardioprotective efficacy of volatile 
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anesthetics (Landoni,2009). The first clinical trial that investigates the clinical efficacy of the 
halogenated anesthetics was in 2002 reporting that sevoflurane preserves global 
hemodynamic and left ventricular function with a lower postoperative troponin I compared 
with total intravenous anesthesia (Cason,1997). Desflurane has also been shown to have 
cardioprotective effect in terms of ICU stay and weaning from mechanical ventilation (De 
Hert et al,2003). Anesthetic agents were also investigated for the timing of their usage, 
before or after ischemic episode or continuously during the procedure; sevoflurane has been 
shown to exert its protective effect more when it is used throughout the whole procedure 
(DeHert et al,2004).  
Despite these beneficial effects, it has also been shown that there is no difference in outcome 
of the patients with already jeopardized myocardium. The patients without previous 
unstabil angina or recent myocardial infarction, had lower postoperative mortality after 
sevoflurane anesthesia (Jakobsen et al,2007). In non-coronary cardiac surgeries, desflurane 
and sevoflurane have also been shown to reduce troponin I release and result in better 
outcome in terms of incidence of atrial fibrillation and ICU stay (Landoni et 
al,2007a;Cromheecke et al,2006). However, volatile anesthetic agents revealed no difference 
in interventional cardiac procedures (Landoni et al,2009). 
The lack of data demonstrating the adverse effects, primarily the coronary steal, of volatile 
anesthetics, the preconditioning effects of these agents, resulting in a safe and effective fast-
tracking for patients especially when number of off-pump coronary revascularization is 
rising; has led to an anesthetic management mainly based on volatile anesthetics (London et 
al,2008). Volatile anesthetic agents, in comparison to TIVA, provide reductions in the rates 
of all major end points of cardiac surgery; reduce the risk of myocardial infarction and all-
cause mortality; increasing in-hospital survival, reducing troponin I release, reducing the 
need for inotropic support, shortening ICU stay, time to hospital discharge and time on 
mechanical ventilation. These effects are valid for CABG surgery with or without 
cardiopulmonary bypass (Landoni et al,2009).  
A recent meta-analysis the choice of desflurane and sevoflurane results in better outcome in 
terms of mortality and cardiac morbidity in cardiac surgical patients (Landoni et al,2007b). 
Although the results are controversial, the most recent American College of Cardiology/ 
American Heart Association guidelines recommend the usage of volatile anesthetic agents 
for non-cardiac surgical patients at risk for MI (Fleisher et al,2007). 
2.4.2.1 Preconditioning effects of volatile anesthetic agents 
Myocardial infarction is one of the most serious perioperative complications, that makes 
myocardium one of the most important vital organ to be protected from ischemia during 
cardiac and non-cardiac surgeries (Landoni et al,2009; Lango&Mrozinski et al, 2010). 
Ischemic insult is an integral part especially of cardiac surgery, that reducing the risk of 
myocardial infarction has led to researchs and revealed anesthetic management as an 
important factor in protecting myocardium. 
A powerful cardioprotective phenomenon was first described in 1986, as an adaptive 
response to brief sublethal ischemic episodes that are exerted on myocardium, providing 
protection against subsequent lethal ischemia. This is called ischemic preconditioning, 
which is not very easy to apply clinically, because of the risk of worsening the vulnerable 
myocardium (Landoni et al,2009). Oxygen inflow to the heart is discontinued for short terms 
before the main ischemic episode in ischemic preconditioning, which has been shown to 
provide higher levels of ATP in myocardium and lower levels of troponin I after surgery. As 
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reperfusion begins, ischemia will result in rapid changes during the reperfusion period; 
which is called reperfusion injury contributing to impaired function of endothelium and 
reduced metabolism of cardiocytes.  Reperfusion injury may also be attenuated by ischemic 
preconditioning by restoring blood flow intermittently through the organ. In order to 
provide optimum protection, timing becomes important as the intervention should be 
performed within a few minutes or during the first minute of coronary blood flow 
restoration (Lango&Mrozinski et al,2010). Since the ischemic preconditioning is difficult to 
apply in clinical practice, pharmacological preconditioning comes to our way. 
In general, the mechanisms of the myocardial protection provided by anesthetic agents may 
include; an effect like ischemic preconditioning, prevention of excessive calcium influx to 
the cell, an effect like antioxidants and an effect on the relationship between 
neutrophil/platelet-endothelium. The signalling throughout the cell during anesthetic 
preconditioning include protein kinase C (PKC), protein tirozin kinase (PTK), mitogen-
activated protein kinases (MAPK), protein kinase-B, mitochodria and ion channels 
(sarcolemmal and mitochodrial ATP-dependent potassium channels) (Figure 1) 
(Lorsomradee et al,2008). 
In pharmacological preconditioning, activators of protein kinases, agonists of adenosine 
receptors, scavengers of free radicals, opioids, ethyl alcohol, acetylcholine, bradykinin, 
angiotensin II, noradrenalin, platelet-activating factor were all used, but most of them can 
not be used for their protective effects because of their side effects or insufficient data of 
their clinical efficacy (Lango&Mrozinski,2010). In experimental studies, although the exact 
mechanism is not known, volatile anesthetic agents, known to have cardiac depressant 
effects that reduces myocardial oxygen demand, were demostrated to have direct 
cardioprotective effects that are not related to their anesthetic or hemodynamic effects 
(Landoni et al,2009).  
Anesthetic preconditioning depends on the concentration of the drug and also the duration 
of administration, it does not depend on ischemic preconditioning and does not need pre-
emptive ischemic episodes, furthermore it may have only slight protective effects on the 
heart that is already exposed to ischemic preconditioning (Landoni et 
al,2009;Lango&Mrozinski,2010). There are also some factors such as ǃ-blocker usage and 
perioperative hyperglycemia that may limit the effectiveness of volatile anesthetics. Volatile 
anesthetic agents can provide their protective effects both before and after ischemia and also 
during the reperfusion period. In order to achieve maximum cardioprotection in surgeries 
including ECC, volatile anesthetics should be used before aorta clamping at >1 MAC for 
longer than 15-30 minutes. Also for the postconditioning effect, to provide adequate 
concentrations in blood after unclamping, the agents should be initiated several minutes 
before unclamping via the oxygen-air supply line of ECC and continued for the first 2-5 
minutes of reperfusion. The effectiveness of usage during aorta clamping and  late 
reperfusion period has not been clearly demonstrated yet (Lango&Mrozinski,2010). As an 
analogy to ischemic postconditioning, anestetic postconditioning describes the usage of 
volatile anesthetic agent after ischemic period contributing to the reperfusion period. This 
should be done within the first 2 minutes, lenghtening the period does not improve the 
protective effects (Obal et al, 2003).  The protection occurs at two stages; early, lasting for 
one or 2 hours and late preconditioning, reappearing after 24 hours, lasting up to 72 hours; 
which means that the protective effect markedly exeeds the drugs elimination time (Landoni 
et al,2009;Lango&Mrozinski,2010).  
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Fig. 1. The cellular mechanism of the preconditioning with volatile anesthetic agents. 
Volatile anesthetic agents  activate phospholipase-C (PLC) and provide opening of the ATP-
sensitive potassium channels by stimulating the adrenergic receptors by adenosine A1 and 
A3 (A1/A3) and activating nitric oxide sythase. (Lorsomradee et al,2008).  
B2: bradikinin receptors, Gi protein: Inhibitory guanine nucleotide binding proteins, MAPK: 
mitogen activated protein kinases, PIP2: phosphotidil inositole bisphosphate, DAG: 
diacylglycerol, ITP: inositole 1,4,5 triphosphate, NO: nitric oxide, ǂ1: ǂ1-adrenergic receptor,  
ǃ: ǃ-adrenergic receptor,  δ1: opioid receptors, PKC: protein kinase-C,  ROS: reactive oxygen 
species, SR: sarcoplasmic reticulum (Lorsomradee et al,2008). 
2.4.3 Fast-track cardiac anesthesia (FTCA) 
FTCA contributes to an anesthetic management with a goal of allowing rapid recovery after 
surgery (Bainbridge&Cheng,2009). Fast-tracking with early extubation (4-8 hours 
postoperatively) has become the standart of care recently. The patients with normal LV 
function preoperatively and an uneventful intraoperative course, as long as the 
hemodynamic stability is ensured, by avoiding high doses of respiratory depressant 
anesthetics, with adequate rewarming and postoperative analgesia may be candidates for 
early extubation (London et al,2008).  
The two most actively investigated methods in FTCA practice are; intraoperative narcotic 
that best facilitates FTCA and the pain control during the recovery period. The narcotics 
examined for their efficacy are fentanyl, remifentanil and sufentanil, which have been 
found to result in similar times to extubation (Cheng et al,2001;Engoren et 
al,2001;Mollhoff et al,2001). TEA has been reported to be superior to placebo and spinal 
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narcotics in terms of pain control (VAS), narcotic consumption, pulmonary complications, 
dysrhythmias and time to tracheal extubation. However, the risk of epidural hematoma 
formation limits its usage (Liu et al,2004;Ho et al,2000). A meta-analysis demostrated that 
PCA in cardiac surgical patients has little benefit whereas NSAIDs provide a reduction in 
VAS scores and morphine consumption (Bainbridge et al,2006a,2006b). Nurse 
administered or patient administered narcotics combined with NSAIDs (if there is no 
contraindication) is the recommended approach for postoperative pain management 
(Bainbridge &Cheng,2009). 
The delay in tracheal extubation may be caused by many factors such as; age, female sex, 
postoperative bleeding, inotrope use, IABP and atrial arrhythmias (Wong et al,1999). During 
the operation, the usage of low dosage of narcotics balanced with inhaled agents and/or 
propofol providing a rapid reversible state facilitates early extubation. The complications 
associated by inadequate control of temperature, hemodynamics, and/or coagulation may 
also result in delayed extubation (Bainbridge &Cheng,2009). 
The criteria that is suggested for early tracheal extubation includes a stable body 
temperature of 36-38 C, an arterial pH >7.30, adequate arterial blood gases contributing to 
PaO2>70-80 mmHg (Fio2=0.4-0.5), PaCO2<40-45 mmHg. The patient should be awake, 
cooperative, alert and able to move all extremities with adequate motor strenght. The 
hemodynamic parameters should be stable with minimal or no need for inotropes with 
stable rhythm or good response to pacing. The patient should be spontaneously breathing 
with minimal respiratory support at a rate of >10-12 and <25-30 breaths/min with a VC>10 
ml/kg, a maximal negative inspiratory force>-20 cmH2O and a chest radiograph without 
major abnormalities such as atelectasis. Also adequate urine output, stable electrolytes, 
adequate hemostasis should be achieved (London et al,2008). 
2.4.4 Regional anesthesia techniques 
Advances in anesthesiology improves outcome after cardiac surgeries by combining the 
regional anesthesia techniques with general anesthesia. Thoracal epidural anesthesia (TEA) 
may enhance coronary perfusion, improve myocardial oxygen balance, reduce the incidence 
of tachyarrhythmias, perioperative myocardial ischemia through sympaticolytic effects; and 
also by providing superior analgesic effect it facilitates early tracheal extubation and may 
prevent respiratory complications (Svircevic et al,2011). However, because of the 
complications especially the epidural hematoma or abcess formation, TEA usage in cardiac 
surgeries is controversial. Moreover, the chronic use of antiplatelet agents, use of systemic 
anticoagulation and platelet inhibition for acute therapy of unstable angina and systemic 
anticoagulation and potential coagulopathy induced by CPB may increase the incidence of 
these complications (Ho et al,2000;London et al,2008). Also the systemic hypotension caused 
by intense sympaticolysis may be difficult to correct. The beneficial effects on respiratory 
system has also been shown to be provided by other strategies; such as spinal anesthesia 
(Cheng et al,1996; Silbert et al,1998). A meta-analysis by Liu reported that pulmonary 
complications can also be reduced by spinal anesthesia; as the incidence of hematoma 
formation is lower after a single spinal injection, this technique can be a choice for cardiac 
surgical patients at risk for pulmonary complications (Liu et al,2004). Also, modern general 
anesthetics can also provide other beneficial effects such as earlier extubation. TEA should 
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2.4.5 Awareness and recall 
The cardiac surgical patients are at increased risk for intraoperative awareness and recall, 
especially due to intentional avoidance of the cardiodepressant volatile anesthetics in the 
presence of hemodynamic instability, mostly caused by surgical manipulations of the heart 
and great vessels, leading to light anesthesia periods. As the volatile anesthetics have been 
proven to provide preconditioning before CPB, they began to have a major role in cardiac 
anesthesia protocols reducing the risk of awareness (London et al,2008). 
3. Management during cardipulmonary bypass 
Cardiac surgical patients are often dehydrated and hypoglycemic on admission for the 
operation. Rehydrating the patient and administering sufficient glucose increase the heart’s 
ability to tolerate ischemic arrest. Initiation of bypass results in hypotension, requiring 
vasoactive drugs (e.g. phenylephrine) to maintain coronary perfusion pressure (CPP). Also 
ventricular distention should be avoided in order to maintain CPP and avoid the reduction 
in subendocardial oxygen delivery. After initiation of bypass TEE helps for the intravascular 
volume monitoring. The heart rate should be maintained <80 bpm in patients with ischemic 
heart disease during the pre-bypass period. For this purpose  ǃ-receptor antagonists can be 
used to provide a reduction in myocardial metabolism and maximize coronary blood flow 
(London et al,2008).  
The sternotomy is the most distressing period, particularly in reoperations, in which there is 
a higher risk of right ventricular perforation, damage to existing vein grafts and ventricular 
fibrillation caused by electrocoutery energy transmission through sternal wires; requiring at 
least 2 units of RBC readily available in the operating room (London et al, 2008) 
During dissection of left internal mammarian artery, the operating table should be 
elevated and rotated to left, while tidal volumes are to be reduced to facilitate surgeon’s 
exposure.  
Anticoagulation is provided by administering 300-400 IU/kg heparin and its adequacy is 
measured by using activated clotting time (ACT) which is desired to be 450-500 seconds. 
Higher doses of heparin may be required in case of resistance, however resistance can be 
treated with 1 unit of FFP or recombinant AT III (Kanbak M, 1999;London et al,2008). If 
anesthesiologist is the one to administer heparin, then the central venous line is the site of 
injection, whilst many surgeons prefer to give heparin themselves directly into the RA. 
Before or after anticoagulation, antifibrinolytic therapy may be initiated for bleeding 
prophylaxis. Aprotinin, being once the most popular agent, has been withdrawn from the 
market because of the safety concerns including mortality rate, anaphylaxis and renal 
dysfunction. Tranexamic acid and aminocaproic acid are the major agents that can be used 
instead of aprotinin (Henry et al,2007;Umscheid et al,2007)(see also bleeding and 
transfusion).  
After heparinization, aortic cannulation is established often using the ascending aorta, 
following the examination of the cannulation site to be free of disease (London et 
al,2008;Morgan et al,2002) . In order to minimize the risk of dissection during cannulation 
systolic blood pressure should be lowered to a lowest safe level of 90-100 mmHg (London et 
al,2008).  
Myocardial preservation involving anterograde or retrograde cardioplegia or both, arrest 
with high-potassium cardioplegia and hypothermia (systemic, topical and by cardioplegia) 
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is provided by surgeon and perfusionist (London et al,2008). During cardiopulmonary 
bypass, pump flows, temperature and glucose control, blood gas analysis and management, 
ventilation strategies will be discussed later in this chapter. 
After revascularization, with adequate rewarming (which will be discussed later in this 
chapter), stable rhythm-preferably sinus-good response to pacing, acceptable levels of pH, 
calcium, potassium and hematocrit, adequate ventilation with 100% oxygen; CPB is 
considered to be terminated (Morgan et al,2002). In case of a potential need, inotropes or 
other vasoactive drugs should be readily available. Heparin is reversed by protamin at 1:1 
ratio emprically avoiding rapid injection. The TEE is removed and stomach is aspirated with 
an orogastric tube. The chest tubes and mediastinal drainages are secured as chest is closed 
and get ready for transport (London et al,2008).  
3.1 Oxygen delivery during CPB 
Delivery of oxygen depends on two variables that determine tissue oxygenation; hematocrit 
values and pump flow rates; that the calculation is: DO2= pump flow x ((hemoglobin 
concentration x hemoglobin saturation x 1.36) + (0.003 x arterial oxygen tension)). In the 
clinical setting, increasing pump flows, increasing hematocrit concentrations (transfusion of 
PRBCs or use of ultrafiltration for hemoconcentration), or increasing hemoglobin saturation 
and the amount of dissolved oxygen (increasing the inspired oxygen concentration [FIO2]) 
can improve delivery of oxygen (Lango&Mrozinski,2010). 
Delivery of oxygen during CPB is typically less than that measured in the awake and 
anesthetized subjects. This is primarily caused by the decrease in the arterial oxygen content 
that occurs from hemodilution at the onset of bypass. The reduction in the DO2 is 
compansated by increasing the oxygen extraction ratio which narrows the safety margin 
between oxygen supply and demand. At first this compansation maintains oxygen 
consumption (VO2) stable (flow independent oxygen consumption), when the maximum 
extraction ratio is reached VO2 and tissue oxygenation begin to decrease and lactic acidosis 
develops (flow dependent oxygen consumption). The critical DO2 has not been defined, 
although there are many trials investigating this value; however it is shown that the organs 
undergoing bypass have hierarchy, that with a low pump flow the DO2 of the brain is 
maintained at the expense of other organ systems; kidneys, pancreas, muscle beds. In order 
to preserve organ functions there should be a critical value to be targeted for DO2 rather 
than targeting pump flow rates or a specific hematoctrit value (Lango&Mrozinski, 2010; 
Ranucci, 2009). 
3.1.1 Hemodilution 
Hemodilution is used during the CPB to offset the effect of hypothermia on blood viscosity 
and reduce the need for blood transfusion. However with the decreasing hematocrit level, 
the oxygen carrying capacity decreases and brain compansates for it by increasing CBF and 
tissue oxygen extraction; which leads to increased embolic load. Although an optimum level 
for hematocrit during CPB has not been clearly defined, there is data supporting the 
reservation of transfusion of blood products for the hemoglobin levels of <6 g/dl during 
CPB and <7 g/dl after surgery (Ferraris et al,2007). When there is a risk for end-organ 
ischemia these critical values can be increased by 1-7 gr/dl during CPB. Also it is important 
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Extreme hemodilution in the elderly should be avoided; a decrease in hematocrit from 
baseline of 12 percentage points or greater has been shown to be associated with 
neurocognitive decline (Lombard et al,2010). 
Recent guidelines state that heparin-coated bypass circuits (oxygenator alone or the entire 
circuit) are not unreasonable for blood-conservation (Class IIb, LOE B) 
(Lango&Mrozinski,2010;Ferraris et al,2007).  
Methods to limit the degree of hemodilutional anemia (Lango&Mrozinski,2010) 
 Delaying elective surgery to restore red cell mass to normal levels by using iron, 
erythropoietin 
 Limiting the volume of crystalloid administered pre- and post-CPB 
 Reducing blood sampling in the perioperative period 
 Using retrograde autolog priming of the CPB circuit 
 Minimizing tubing size 
 Using miniaturized CPB circuits 
3.1.2 Intraoperative hemodynamics 
Small and microvascular disease could be a leading cause of dementia in up to two thirds of 
the patients with dementia. The patients who have dementia at baseline have higher 
incidence of postoperative cognitive dysfunction, that may be caused by their susceptibility 
to cerebral hypoperfusion (Lombard et al,2010). Even clinically aymptomatic (no dementia) 
many patients have infarctions and abnormally perfused areas in brain; these patients are 
also vulnerable to cerebral hypoperfusion as the surgical population ages with structural 
changes leading to stiffness in their arteries (Tolwani et al,2008). Cerebrovascular disease 
may then result in oxygen imbalance during surgery. The use of jugular venous bulb 
monitoring or near infrared spectroscopy (NIRS) revealed oxygen desaturation 27-43% 
during rewarming period while cerebral metabolic rate increases (Croughwell et 
al,1994;HL,2005). DWI detects mostly the watershed stroke, which indicate hypoperfusion 
brain injury that has been shown to be caused by a decrease from baseline mean arterial 
pressure (MAP) of >10 mmHg during CPB (Gottesman et al,2006). Maintaining the pre-CPB 
cerebral perfusion pressures may be an acceptable approach (Burgers et al,2006). NIRS has 
been used for the detection of oxygen saturation in order to use interventions such as 
ensuring adequate CPB flow rate, raising the MAP, ensuring normocarbia, deepening 
anesthesia, raising FiO2 and initiating pulsatile CPB flow; and reported to provide lower 
rates of major organ injury (death, myocardial infarction, stroke) and shorter ICU length of 
stay (Murkin et al,2007). 
Blood pressure during CPB is often kept >50 mmHg, however many trials and retrospective 
analysis supporting high pressures as a neuroprotection strategy led the institutions to keep 
the MAP >70 mmHg, especially in elderly; also according to age many centers manipulate 
this critical value; >70 mmHg for >70 year-old, >80 mmHg for >80 year-old (Grogan et 
al,2008). Recent investigations report that the lower limit of cerebral autoregulation may be 
much higher than 50 mmHg, in awake and normotensive adults the lower limit has been 
demonstrated to be 73-88 mmHg (Murphy et al,2009 as cited in Larsen et al,1994;Waldermar 
et al,1989;Olsen et al,1995). Noting that most of the cardiac surgical patients are older, 
hypertensive and have preexisting cerebrovascular diseases, their autoregulatory curve 
becomes shifted to the right, which requires higher MAPs (>70 mmHg) to reduce the risk of 
hypoperfusion (Lango&Mrozinski,2010).  
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Optimum MAP during CPB is affected by many factors, so decision should depend on the 
individual case. High-risk patients may benefit from higher pressures on bypass 
(Lango&Mrozinski,2010). 
Potential advantages of higher MAPs (Lango&Mrozinski,2010) 
 Enhanced tissue perfusion in high risk patients (hypertensive, diabetic, elderly) 
 Improved collateral flow to tissues at risk of ischemia 
 Allows for higher pump flow rates 
Potential advantages of lower MAPs 
 Less trauma to blood elements 
 Reduction of blood in the surgical field 
 Less cardiotomy suction 
 Allows usage of smaller venous and arterial cannulae 
 Enhanced myocardial protection (reduced collateral coronary blood flow) 
 Reduced embolic load to the CNS (reduced pump flow) 
Minimally safe pump flow has not been established, however the most commonly used flow 
rate during bypass is 2.2-2.5 L.min-1.m-2 approximating the cardiac index of a normothermic 
anesthetized patient with normal hematocrit. During hypothermia pump flow rate as low as 
1.2 L.min-1.m-2  have been reported to have good clinical outcomes. Although there are 
conflicting results, most studies demonstrated that at pump flow rates of 1.0-2.4 L.min-1.m-2, 
CBF remains constant (Lango&Mrozinski,2010). During severe hemodilutional anemia, 
increasing pump flows can prevent organ injury, that pump flow may be adapted to 
hematocrit levels (Ranucci et al,2005). As mentioned before, targeting a critical value for 
DO2 is more important than targeting pump flows or a specific hematocrit for preserving 
organ function (Lango&Mrozinski,2010;Ranucci,2005). 
3.2 Temperature control 
 Hypothermia has been used for decades for cerebral protection. The beneficial effects of 
hypothermia mainly depend on the two physiologic principles, functional and structural 
cerebral metabolic need for oxygen that are both reduced by temperature; total cerebral 
metabolic rate of oxygen (CMRo2) decreases 6-7 % per degree Centigrade reduction; while 
anesthetic drugs alter only functional CMRo2 (Grigore et al,2009). Thiopental in particular, 
reduces cerebral metabolic rate required by brain function and synaptic activity, which are 
achieved during the isoelectric electroencephalographic state. Additional reduction is 
provided by concomitantly administered hypothermia while preserving CBF-CMRo2 
coupling, may also further reduce CBF. Moderate hypothermia without major suppression 
of neuronal function has been reported to provide better neuroprotection compared with 
isoelectric doses of barbiturates (Klementavicius et al,1996). Similar effect preserving 
coupling can be achieved by minimal alveolar concentration (MAC) or sub-MAC doses of 
volatile anesthetics especially isoflurane. Supramaximal doses uncouple CBF and CMRo2. 
During profound hypothermia (18-20 C) CBF is disproportionately maintained and is 
determined more by arterial blood pressure and systemic vascular resistance than by pump 
flow rates (Grigore et al,2009). Moderate (28 C) and mild hypothermia (32-34 C) was shown 
to have no difference in terms of cognitive dysfunction, however hyperthermia (especially if 
the gradient between the temperatures of nasopharyngeal and CPB perfusate is >2C) in the 
perioperative and postoperative period is clearly associated with neurocognitive decline 
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(Klementavicius et al,1996). Any potential benefit for cerebral protection of hypothermia can 
be offset by inappropriate rewarming. More important than the use of hypothermia is 
avoidance of hyperthermia (Grigore et al,2009). During the rewarming period the returning 
warmed blood from aortic cannula is in close proximity to cerebral circulation. Also cerebral 
temperature may be underestimated from the usual monitoring sites (e.g.nasopharynx, 
esophagus) (Grogan et al,2008). Jugular bulb (JB) is the most reliable site to detect the 
accurate cerebral temperature, because it receives 99% of the CBF; however it takes time and 
money with risks associated with placing the device. Nasopharyngeal site and arterial 
inflow (arterial outlet of membrane oxygenator) temperatures are the closest ones to JB with 
a gradient of 1-2 C (Grigore et al,2009). Mild hypothermia (32-34 C), slow-rewarming during 
CPB (maintaining inflow temperature and nasopharyngeal temperature at or below 37 C as 
the maximum allowable) and avoidance of hyperthermia are the current recommendations 
(Grigore et al,2009;Grogan et al,2008). 
The effects of hypothermia 
 Reduction in cerebral metabolism 
 Suppression of free radicals 
 Inhibition of destructive enzymatic reactions 
 Reduction in metabolic requirements in low-flow regions 
 Inhibition of the biosynthesis, release and uptake of exitatory nerotransmitters 
 
 Favorable balance between oxygen supply and demand 
 Slows the onset of ischemic depolarization 
 Decreases the release of ischemic-induced intracellular calcium influx 
 Suppresses nicric oxide synthase activity 
The effects of hyperthermia 
 Increased production of free radicals 
 Widening of any cerebral ischemic penumbral zone that developed intraoperatively 
 Development or expansion of oxygen supply and demand mismatch 
 Increased levels of intracellular acidosis 
 Increase in the response of exitatory aminoacid neurotransmitters 
3.3 Glucose control 
In diabetic patients hyperglycemia may have caused an impaired endothelial function and 
may attennuate preconditioning. Serum potassium abnormalities should be corrected by 
glucose and acid-base management. Insulin continuous infusions are recommended for poor 
glycemic controls, however the possible development of insulin resistance during 
hypothermic CPB should be considered. Oral hypoglycemic agents; metformin may cause 
lactic acidosis in patients with low cardiac output state perioperatively, it is to be held 
several half-lives before the operation and glyburide has been shown to block 
preconditioning (London et al,2008). 
In patients who stays more than 5 days in ICU, aggressive glycemic control was clearly 
proven to reduce mortality (Van den Berghe et al,2001). Similarly, in a retrospective analysis 
of cardiac surgical patients a predetermined glucose level (<150 mg/dl) was targeted with a 
continuous insulin infusion for 3 days postoperatively, had reduced risks of death and deep 
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sternal wound infections (Furnary et al, 2004). There are conflicting results about the 
association between hyperglycemia and adverse neurological outcome, and yet whether the 
glycemic control improves neurological outcome is not clear. In diabetic patients 
hyperglycemia has no influence on cognitive functions and in nondiabetic patients >200 
mg/dl glucose level during CPB has been shown to increase the incidence of cognitive 
dysfunction (Puskas et al,2007). Persistent hyperglycemia (>200 mg/dl) for the 24 hours 
after stroke, is an independent indicator for the expansion of cerebral infarction (Baird et 
al,2003). AHA guidelines state that it is reasonable to initiate insulin therapy when glucose 
level is >140-185 mg/dl (Class IIa, LOE C) after stroke (Adams et al,2007). The NICE 
SUGAR trial recommends moderate glycemic control compared to intensive control (Finfer 
et al,2009).  
3.4 Blood gas management 
Arterial blood gas pressures are monitored during the bypass period in order to measure 
the adequacy of oxygenation and CO2 exchange. Hypothermia results in a rightward shift in 
CO2 dissociation (increased solubility) leading to alkalemia. There are two measurement 
and management techniques of arterial  blood gases depending on the temperature-
dependent solubility of CO2; pH-stat (temperature corrected) and ǂ-stat (not temperature 
corrected). During CPB mostly the measurement and management are done without 
correction. In ǂ-stat management blood is taken from the hypothermic patient and 
measured at 37 C; the results are uncorrected and the patient remains alkalotic during CPB. 
In pH-stat management, the measured partial pressures are corrected for the patients 
temperatures from the published nomograms, CO2 is added to gas mixture to correct the 
respiratory alkalosis and low PaCO2. Although there are controversies about the method to 
be used, pH-stat has been shown to increase the incidence of cerebral injury via obliterating 
the pressure autoregulation of cerebral blood flow, while ǂ-stat remains to be used in adults 
preserving pressure autoregulation (Oakes&Mangano,2009). 
4. Most common adverse events after cardiac surgery 
4.1 Postoperative atrial fibrillation 
Postoperative atrial fibrillation (POAF) is the most common atrial arrhythmia after cardiac 
surgery; its importance has become considerable because of the adverse effects it is 
associated with; such as congestive heart failure, increased need for intraaortic balloon 
pump, ventricular arrhythmias, cardiac tamponade, perioperative myocardial infarction, 
need for permanent pacemaker implantation, infection, increased postoperative bleeding, 
pneumonia, prolonged mechanical ventilation, increased need for tracheostomy, renal 
failure, stroke and neurological complications including cognitive dysfunction persisting 6 
weeks after surgery , although the role of POAF as a cause of these adverse effects has not 
been clearly defined (Nair,2010). POAF occurs 30% after isolated CABG, 40% after valve 
surgery and 50% after combined CABG and valve surgery; mostly between days 2 and 4 
(Echahidi et al,2008). The attribution of the mechanisms of atrial fibrillation in general 
population to POAF is difficult that it is not clear. Multiple factors such as ectopic focal 
depolarization originating from pulmonary veins and inferior vena cava, redistribution of 
fluid into vascular compartment causing atrial stretch, inadequate atrial protection during 
aortic cross-clamping, systemic inflammatory response syndrome thus elevated 
inflammatory mediators in the cardiac chambers and oxidative stress, excessive sympathetic 
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and parasympathetic nervous system activity, as well as physical alterations resulting from 
incisions to atria may cause POAF (Nair,2010; Grogan et al,2008).  
Postoperative atrial fibrillation (POAF) as being associated with various adverse events 
should be assessed preoperatively and measures to prevent this adverse event should be 
considered before the operation. Most of the anti-arrhythmic agents that is to be used for 
prevention of POAF have their own side-effects, that prophylactic usage of these agents 
should be reserved for patients who are at increased risk for developing POAF. Prevention 
begins with identifying the patients with potential to develop atrial fibrillation after cardiac 
surgery (Nair,2010). 
Risk factors for POAF; 
 Valvular heart disease 
 Right coronary artery stenosis 
 Preoperative digoxin use 
 Male gender 
 Rheumatic heart disease 
 Left ventricular hypertrophy 
 Chronic obstructive pulmonary disease 
 Diabetes mellitus 
 Mild renal dysfunction 
 Type of surgery 
 Duration of surgery 
 Prolonged aortic cross-clamping 
 Withdrawal of beta-blockers and/or ACE inhibitors 
 Bi-caval venous cannulation (vs single atrial cannula) 
 Right superior pulmonary vein cannulation (for left ventricle decompression) 
 Cardioplegia 
 P wave duration more than 140 ms (Nair, 2010, as cited in Steinberg et al,1993) 
 Left atrial appendage area >4 cm2 and post-CPB left superior pulmonary vein 
systolic/diastolic velocity ratio <0.5 (combined with >75 years of age; probability is 
0.83)(Nair, 2010, as cited in Karthikeyan et al,2009) 
 Elevated preoperative BNP/NT-BNP (N-terminal pro-B type natriuretic peptide) (Nair, 
2010, as cited in Karthikeyan et al,2009) 
 Perioperative use of milrinone causing elevated cyclic AMP levels (Nair,2010,as cited in 
Fleming et al, 2004) 
4.1.1 Prevention of postoperative atrial fibrillation 
Pharmacological methods 
Β-Blockers: The withdrawal of ǃ-blockers is a well known cause for POAF. American Heart 
Association (AHA), American College of Cardiology (ACC) and European Society of 
Cardiology recommends usage of ǃ-blockers for prevention of POAF (Class I, LOE A) and 
give a Class IIb, LOE B indication for sotalol (Fauster et al,2006). In a meta-analysis 
investigating the effect of sotalol vs the other ǃ-blockers revealed that it is superior to the 
others in preventing POAF, but although not statistically significant sotalol has major 
bradycardia and hypotensive effects with a significant incidence of torsade-de-pointes 
(Mitchell et al,2007). 
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Amiodarone: Amiodarone can be used oral or intravenous both before and after the surgery 
for the prophylaxis of POAF. Amiodarone has been shown to be associated with 
bradycardia and hypotension (Nair,2010). ACC/AHA/ESC give a Class IIa LOE A 
indication for amiodarone (Fauster et al,2006). American College of Chest Physicians 
(ACCP) suggests that amiodarone should be an alternative for patients who have 
contraindication for ǃ-blockers and Canadian Cardiovascular Society also gives a Class IIa 
recommendation for amiodarone for the patients who have not been on ǃ-blockers for the 
prevention of POAF (Bradley et al,2005;Mitchell et al,2005).  
Calcium-Channel Blockers: Calcium-channel blockers were shown to reduce the incidence 
of myocardial infarction, ischemia and also tend to reduce mortality. However, these agents 
exert negative inotropic and negative chronotropic effects which may cause an increase in 
the incidence of atrioventricular block and low-output syndrome (Nair,2010 ).  
Magnesium: Magnesium deficiency occurs and may persist for at least 4 days after cardiac 
surgery. Although ACC/AHA/ESC do not recommend the usage of magnesium as 
prophylaxis for  POAF and ACCP is against its usage, CCS gives Class IIa indication for 
magnesium usage for patients who are not on beta-blocker therapy (Fauster et al,2006; Nair 
et al,2010). If magnesium therapy is to be used, it should not be limited to the early 
postoperative period, that the magnesium deficiency may persist for at least 4 days after 
cardiac surgery (Nair et al,2010).  
Other Pharmacological Methods: Digoxin (limited effect) (Mitchell et al,2005), statins 
(shown to have beneficial effects) (Liakopoulos et al,2009), procainamid (limited usage 
because of the well-known side effects of Class I antiarrhythmic agents on structural heart 
diseases) (Nair,2010) and methylprednisolon (beneficial with anti-inflammatory activity but 
limited usage because of renal adverse side-effects) (Prasongsukarn et al,2005) has been 
investigated for the prophylaxis of POAF.  In patients who have high-risk for the 
development of AF it is important to continue beta-blockers including the operation day 
and restart at the earliest postoperative period and as a prophylactic measure to initiate 
intravenous amiodarone therapy. 
Other methods  
Since pericardial effusion has been shown to be an important cause for POAF, posterior 
pericardiotomy allowing drainage to left pleural space has been investigated and shown to 
reduce the incidence of supraventricular arrhythmias (Nair,2010). Prophylactic atrial pacing 
has been shown to reduce the development of POAF. Bi-atrial pacing revealed more 
significant reduction in POAF vs left or right atrial pacing or no pacing (Fan et al, 2000). It 
has also been shown to be as effective as the pharmacological measures (Crystal et 
al,2004;Burgers et al,2006). 
4.1.2 Treatment of postoperative atrial fibrillation 
POAF is a self-terminating but recurrent tachyarrhythmia that usually subsides in 6-8 weeks 
after cardiac surgery. It should be kept in mind that the adrenergic response in the 
postoperative period will reduce the effectiveness of any therapy that does not include beta-
blokers (Nair,2010). POAF treatment should prevent thromboembolism, control ventricular 
rate, improve hemodynamics, convert and maintain the sinus rhythm and in-long-term 
prevent tachycardia-associated cardiomyopathy. The treatment strategy that targets only the 
rate control may not prevent the adverse effects that are caused by atrial fibrillation. Rhythm 
control has been shown to be no superior than rate control, however, if the symptoms are 
www.intechopen.com
 
Anesthesia in Cardiac Surgery 
 
35 
not over with rate control only, then rhythm control should also be managed. Rhythm 
control is recommended for patients who are still symptomatic despite adequate rate control 
and who cannot achieve an adequate rate control despite therapy. Since it is self-limited, 
there is no need for long-term therapies for the patients who have normal left ventricular 
function and restored sinus rhythm. Amiodarone at a maintenance dose for 1 month, up to 3 
months maximum, can be used for that kind of patients. Patients with impaired left ventricle 
function may require longer therapy. ACC/AHA/ECS recommend anticoagulation in 
addition to rate control (Nair,2010; Fauster et al,2006).  
Rate Control: The goal in the control of heart rate is 80-90 beats/min after cardiac surgery, 
however it should be kept in mind that rate should be titrated in order to achieve a stable 
hemodynamic profile and myocardial oxygen balance. Beta-blockers and amiodarone are 
the first-line agents to be used for the treatment of POAF (Class I) (Nair,2010;Mitchell et 
al,2005). Calcium-channel blockers are the other effective agents to be used; diltiazem has 
been shown to be better tolerated than verapamil. Although digoxin is recommended for the 
ventricular rate control in patients with AF and congestive heart failure, without pre-
exitation syndromes,  has limited efficacy in the postcardiac surgery setting most probably 
because of the increased sympathetic response after surgery (Nair,2010).  
Rhythm Control: Although it is self-limited, frequent recurrence is a rule for POAF. After 
pharmacotherapy in normal setting and also in the settings of recurrence and refractoriness, 
pharmacological and/or electrical cardioversion to sinus rhythm is also recommended. 
Amiodarone is the anti-arrhythmic agent to be used for pharmacological cardioversion, 
propafenon has been shown to be as effective as amiodarone; procainamid, dronedarone are 
the agents investigated for efficacy and safety, however they have side-effects and limited 
efficacy compared to that of amiodarone (Nair,2010). 
Electrical Cardioversion: Postoperative atrial fibrillation may cause hemodynamic 
deterioration, myocardial ischemia, worsening left ventricle function, rapid ventricular 
response, which requires electrical cardioversion. The adequate waveform and energy level 
should be chosen; 120-200 j biphasic and 360 j monophasic is the Class IIa, LOE A 
recommendation (Neumar et al,2010). When it comes to increasing the dose stepwise, it is 
important to differantiate the ‘failure to cardiovert’ and ‘early re-initiation of AF’. If even a 
single beat of sinus rhythm does not occur after cardioversion, it is failure to cardiovert, then 
increasing the delivered energy level, greater pressure on paddles, internal cardioversion 
and repeating cardioversion after anti-arrhythmic therapy can be tried. However, if it is 
early re-initiation of AF, additional measures may also end up in the same situation and 
may be harmful; that initiation of antiarrhythmic therapy (intravenous amiodarone (high 
ventricle rates) or diltiazem) and correction of the possible contributing factors (e.g. pain, 
electrolyte imbalance) before the next electrical cardioversion attempt (24-36 hours later) is 
recommended. If the unstability continues, DC cardioversion should be given after a bolus 
dose of amiodarone. For the patients who are stable with a low ventricular rate, observation 
is recommended until 24-48 hours, if AF still continues DC cardioversion may be attempted 
(Nair,2010). Combining the pharmacological therapy (amiodarone for at least 7 days, if 
recurrent AF at least 1 month) with electrical cardioversion prevents the recurrence of atrial 
fibrillation. 
As mentioned earlier, anticoagulation is recommended for patients who receive 
pharmacological and/or electrical tharpies, because in both cardioversion strategies there is 
1-7% risk of thromboembolism. Although the applicability of anticoagulation strategy after 
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cardioversion in non-surgical patients (3-4 weeks of anticoagulant therapy before 
cardioversion in AF more than 48 hours) for cardiac surgical patients is not clear, it is 
acceptable to use echocardiography especially for left atrial appendage mural thrombus, 
immediately placing patient on heparin and continue with oral anticoagulants for 3-4 weeks 
after cardioversion (Echahidi,2008). POAF is well known to increase the incidence of 
thromboembolism and stroke, but it is also well known that anticoagulation may result in 
bleeding and cardiac tamponade. Risk-benefit should be considered before anticoagulant 
therapy is initiated, especially for patients with advanced age, uncontrolled hypertension 
and history of bleeding. 
4.2 Postoperative bleeding and transfusion 
One of the most important adverse events after CABG is excessive blood loss, resulting in 
blood transfusion which increases mortality risk, ischemic morbidity, infections, hospital 
stay and overall health care costs following CABG (Augoustides et al,2009).  
In order to prevent blood loss, it is important to identify the patients with increased risk of 
bleeding and also the patients who may develop adverse events related to transfusion. 
Advanced age, low preoperative red cell volume, preoperative usage of antithrombotic and 
antiplatelet drugs, reoperations, combined procedures, emergency surgery and co-
morbidities are the major contributing factors to the risk of bleeding (Augoustides et 
al,2009). Limiting bleeding and tranfusion after CABG begins with adequate preparation of 
the operating room and ICU with full institutional support. A guideline to lead a systematic, 
standardized approach is also an important factor for limiting bleeding and tranfusion 
(Ferraris&Spiess,2007). 
In the preoperative period usage of anticoagulants leads to an increased risk of bleeding, 
thus if clinically feasible, the anticoagulants should be stopped allowing coagulation system 
to recover (Augoustides et al,2009). Clopidogrel, a high-intensity platelet blocker, is 
reasonable to be discontinued for at least 5-7 days before surgery (Ferraris&Spiess,2007). 
The low-intensity antiplatelet aspirin therapy is recommended to be stopped in elective 
patients without acute coronary syndromes (Ferraris et al,2002).  
In combination with appropriate erythropoietin and iron therapy, donation of 2 units of 
autologous blood before CABG, significantly reduces allogenic blood transfusions. 
Kahraman et al. reported that acute intraoperative hemodilution reduces the blood 
requirements without affecting RBC volume loss and high-volume phlebotomy does not 
provide any additional benefit (Kahraman et al,1997). Antifibrinolytic agents can be used to 
limit bleeding and transfusion; tranexamic acid and aminocaproic acid are the major agents 
that can be used instead of aprotinin, providing a reduction in bleeding and blood 
transfusion; especially recommended for their usage in the high-risk subgroups (Henry et al, 
2007; Umscheid et al, 2007). Desmopressin is reserved for patients who have pletelet 
dysfunction in the preoperative period and also factor 7a therapy has been shown to be 
effective in the management of refractory bleeding after CABG (Warren et al,2007). 
As it exerts a mechanical pressure on the heart PEEP can be used to limit bleeding and need 
for transfusion. 
Off-pump CABG is a resonable alternative for the prevention of blood loss, however emergent 
conversion to CABG with CPB increases blood loss and risk of transfusion (Jin et al,2005). 
Several parts of CPB circuit have been improved for patient safety. Membrane oxygenators, 
centrifugal pumps, heparin-coated circuits, minimized low-prime CPB circuits are the 
recommended types for these parts of the circuit (Augoustides et al,2009). 
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High-dose heparin therapy preserves coagulation during CPB and also may decrease 
bleeding and transfusion. The reversal of heparin with protamine may affect bleeding and 
tranfusion as protamine itself is an anticoagulant. Despite the lack of definitive data, 
titration and empric low-dose regimen of protamine therapy may both lower the dosage of 
protamine and reduce bleeding and tranfusion (Jobes et al, 1995; Shore-Lesserson et al, 
1998). 
Leukofiltration, ultrafiltration or infusion of shed mediastinal blood are other interventions 
that are addressed in clinical trials (Augoustides et al,2009).  
In general, in CPB, it is reasonable to maintain hemoglobin >10 gr/dl in patients who are at 
risk of non-cardiac end-organ ischemia; and >7 gr/dl in patients who are at risk of critical 
end-organ injury (Augoustides et al,2009). 
4.3 Neurocognitive dysfunction  
Adversely affected central nervous system is a well-defined problem following cardiac 
surgeries especially requiring hypothermic circulatory arrest. However, it is not clear that 
these neurological problems are related to procedure itself or to the underlying 
cardiovascular disease. In that point of view Wahrborg et al. found no difference between 
percutaneous coronary interventions and CABG (Wahrborg et al,2004). The most 
frequently reported form of brain injury is postoperative neurocognitive decline (POCD), 
of which recovery is variable, mostly transient, also which may prolong for several years 
and has no known treatment, leading the search for finding various interventions to 
reduce this decline (Lombard et al,2010;Grigore et al,2009). The other forms of brain injury 
such as stroke and encephalopathy have incidences of 1-5.2% and 10% respectively; when 
compared to POCD the difference is striking; 10-60% at 6 months (Funder et 
al,2009;Newman et al,2006). Early decline rate is 50-70% within the first week, 30-50% 
after 6 weeks and 20-40% at 6 months and first year. As mentioned before, multiple 
factors influence cognitive functions including surgical recovery and analgesic and 
sedative requirements, that it is difficult to accuse procedures only for the adverse 
neurocognitive decline. It is well-known that most patients with advanced coronary artery 
disease already have neurocognitive decline before surgery and have more potential to 
develop further decline independent of surgery (Lombard et al,2010). Selnes et al (2008) 
reported that there is a significant late decline in neurocognitive functions after CABG 
sugeries, however no significant difference compared to non-surgical patients with 
coronary artery disease. The degree of preexisting vascular disease may influence adverse 
neurocognitive outcomes after CABG more than expected, as the results of many trials 
suggest the natural progression of cerebrovascular disease is the main determinant of 
cognitive decline rather than CABG (Lombard et al,2010;Grogan et al,2008).  
The clinical forms of brain injury and their frequencies (Grogan et al, 2008) 
 Stroke  
 Low risk patients    <1% 
 High risk patients   5%-16% 
 Encephalopathy    8.4%-32% 
 Neurocognitive dysfunction 
 Hospital discharge   40%-75% 
 1 month after surgery   12%-30% 
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In the preoperative period, brain imaging can detect the prior brain infarction, white matter 
lesions and/or lacunar infarcts that are clinically asymptomatic and also abnormal brain 
perfusion areas can be detected by SPECT prior to the operation; demonstrating the high-
risk patients for the development of POCD. 
There are several factors that have been associated with neurological problems such as 
patient risk factors including aortic atherosclerosis and surgical risk factors including type 
of surgery, temperature control, glucose control and intraoperative hemodynamics. 
4.3.1 Risk factors of neurocognitive dysfunction 
Patient Risk Factors; Neuroprotective anesthetic, surgical and perfusion techniques should 
be the key element in the management of these procedures guided by the identification of 
the high risk  patients in the preoperative period.  
Patient risk factors (Lombard et al,2010;Grigore et al,2009) 
 Advanced age (>70 yr) 
 Non-coronary manifestations of atherosclerosis; 
History of cerebrovascular disease with symptoms or silent infarctions (presence of one 
or more lacunar infarcts on preoperative magnetic resonance imaging) 
Peripheral vascular disease 
 Chronic neurologic illness 
 Congestive heart failure 
 Fewer years of education 
 Limited social support 
 Insulin-dependent diabetes mellitus 
 Genetic predisposition (minor alleles of C-reactive protein (CRP; 3’UTR 1846C/T), IL-6;-
174G/C, platelet glycoprotein IIb/IIIa receptor variants are the candidates requiring 
further knowledge)(Grogan et al,2008) 
Surgical risk factors; 
 CPB 
 Blood gas management 
 Cerebral embolism 
 Cell salvage 
 Valve surgery 
 Temperature control 
 Hemodilution 
 Oxygen delivery 
 Glucose control 
 Intraoperative hemodynamics 
 Aortic atherosclerosis 
 Systemic inflammatory response  
4.3.2 Prevention of adverse neurological outcome 
CPB; Cerebral hypoperfusion, temperature fluctuations, high incidence of cerebral 
embolism, inflammatory response, brain swelling and elevated levels of biomarkers of brain 
injury explains the potential of CABG surgeries for the development of POCD. However, in 
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recent trials the cardiac surgical patients with or without CPB were investigated and no 
difference was described between them in terms of neurological outcome (Lombard et 
al,2010; Grigore et al,2009). 
Blood gas management; Although there are controversies about the technique to be used 
during CPB period, ǂ-stat has been shown to preserve pressure autoregulation and 
recommended for the technique to be used in adults (see also management during CPB). 
Cerebral Embolism; Long-term dysfunctions might be mostly related to macroemboli from 
aortic lesions due to aortic manipulation, rather than gaseous microemboli which is the 
predominant type of microemboli during bypass period (Wahrborg et al,2004). However, 
the macroemboli to be a major cause of cognitive dysfunction is unlikely that it has been 
defined to be more associated with stroke (Bar-Yosef et al,2004). As being the most common 
type of cerebral emboli detected by transcranial Doppler during CPB are air emboli; in order 
to increase the rate of absorbtion of intravascular emboli, CO2 has been used for wound 
insufflation to replace air in the pericardium, as it is more soluble than air. Although it 
reduced the number of arterial emboli, it has not been investigated for the brain protection, 
and also this technique is not without risks (Grogan et al,2008). The imaging techniques 
improves every year and one of them is the magnetic resonance diffusion-weighted imaging 
(DWI), which identifies regions of cerebral ischemia with a high sensitivity and specificity 
differentiating the acute from chronic infarction. 25-50% of patients undergoing cardiac 
surgery develop new lesions on DWI, however, very few of them show clinically significant 
infarction. On the other hand there are trials reporting significant correlation between the 
lesions on DWI and cognitive impairment proving that for the development of cognitive 
dysfunction, necrosis is not necessary, whereas other trials did not reveal any correlation 
(Knipp et al,2005;Cook et al,2007). More sensitive imaging techniques such as functional 
MRI may be used for assessing neurocognitive dysfunction after cardiac surgery. 
Cell Salvage; Continuous flow cell saver when compared with conventional cardiotomy 
suction,  may reduce the lipid microemboli (resulting in small arteriolar capillary 
dilatations) by processing the shed blood a major source of lipid microparticulates, thus 
reduce the cognitive decline after cardiac surgery (Grogan et al 2008, as cited in Djaiani et 
al,2007). Simply discarding the pericardial aspirate, when the shed blood is low, is an 
acceptable choice; and on the other hand using the cell-saver may cause thrombocytopenia 
and decrease the concentration of coagulation factors leading to bleeding and high rates of 
transfusion. Thrombocytopenia is a major concern because transfusion of platelets increases 
the risk of stroke in cardiac surgical patients. The increased requirement for transfusion has 
been shown by both Rubens et al. (Grogan et al,2008 as cited in Rubens et al,2007) and 
Djaiani et al. (Grogan et al 2008, as cited in Djaiani et al,2007), although their results in terms 
of the effects of cell-saver and cardiotomy suction on neurocognitive dysfunction are 
conflicting.  
Valve Surgery; The valve surgeries have an increased incidence of cognitive dysfunction, 
because of the open heart chambers during the procedure. Furthermore the cognitive 
dysfunction following valve surgery lasts longer than CPBG surgeries most probably 
because of the ongoing microemboli (Lombard et al,2010). 
Temperature Control; Hypothermia has been the major intervention that is used for 
cerebral protection. Moderate and mild hypothermia were not dissimilar in terms of POCD, 
however hyperthermia has been proven clearly to be associated with adverse neurologic 
outcome. The potential benefit of hypothermia is clearly offset by inappropriate rewarming, 
which leads to cerebral hyperthermia. Mild hypothermia (32-34 C), slow rewarming, 
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avoiding hyperthermia are the current recommendations (Grigore et al,2009;Grogan et 
al,2008) (see also management during CPB).  
Hypothermic Circulatory Arrest: Moderate or profound hypothermia with periods of 
circulatory arrest combined with selective anterograde or retrograde brain perfusion periods 
has become an acceptable technique. Selective anterograde perfusion has been proven to be 
comparable or better than hypothermic circulatory arrest alone or retrograde perfusion; 
furthermore it has been reported that shortened period of brain ischemia via selective 
anterograde perfusion and use of less profound hypothermia is associated with good 
clinical outcomes (Reich et al,2010).  
Hemodilution; In order to avoid the adverse effects of hypothermia on blood viscosity, 
hemodilution is used, which also reduces blood requirement during cardiac surgery. As 
hematocrit level decreases, oxygen carrying capacity decreases which in turn increases CBF 
leading to a high risk of cerebral emboli. Although a definitive recommendation is not 
available, transfusion of blood products are supported to be reserved for patients with 
hemoglobin level of <6 gr/dl during CPB and <7 gr/dl after surgery (Ferraris et al,2007) (see 
also management during CPB).  
Oxygen Delivery; Delivery of oxygen during CPB period is less than in awake and 
anesthetized patients; particularly because of the hemodilution at the onset of bypass 
reducing the arterial oxygen content. During CPB, delivery of oxygen to the brain is 
preserved at low pump flow rates at the expense of other organs. A critical DO2 value 
should be targeted to preserve organ functions (Murphy et al;2009) (see also 
management during CPB). 
Glucose Control; Moderate glycemic control is recommended instead of tight glycemic 
control, given a Class IIa, LOE C indication for insulin therapy when the glucose level 
exceeds 140-185 mg/dl (Adams et al,2007;Finfer et al,2009).  
Intraoperative Hemodynamics; The patients with pre-existing cerebrovascular diseases 
(CVD) are more vulnerable to cerebral hypoperfusion during CPB. Considering the 
increased age of these patients, most of them already have a symptomatic or asymptomatic 
CVD, which requires maintenance of pre-CPB cerebral perfusion pressures. MAP>70 mmHg 
is supported to be the goal especially in the elderly (Grogan et al,2008). Although there is no 
clear data, pump flow rates of 1-2.4 L/min/m2 have been shown to preserve CBF (Murphy 
et al,2009). 
Aortic Atherosclerosis; As being an important risk factor for the development of cognitive 
dysfunction, detection of atherosclerosis of the ascending aorta provides risk stratification in 
the preoperative period that may lead to a decision of ‘off-pump’ CAB or ‘no touch’ 
approach to ascending aorta in order to prevent any adverse neurological outcome. 
Avoiding ascending aorta manipulations or searching for the atherosclerosis free areas may 
be beneficial, however after CPB it has been shown that CPB itself (due to sandblasting 
effect) may result in new mobile lesions on the sites where previously was mild-to-moderate 
atherosclerosis; at the sites of aortic cannulation and clamping (Reich et al,2010) . 
Systemic Inflammatory Response; It is well-known that CPB causes a profound systemic 
inflammatory response. High baseline level of CRP was found to be associated with greater 
risk of neurocognitive decline. Cerebral ischemia-reperfusion injury also produces a 
profound inflammatory response; p-selectin expression on platelets resulting in platelet 
accumulation, rendering the brain vulnerable to microthrombosis, leading to ischemia 
(Lombard et al,2010). According to recent guidelines it is not unreasonable to use reduced 
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circuit surface and biocompatible surface-modified circuits which are useful and effective in 
reducing systemic inflammatory response (Class IIa, LOE B) (Shann et al,2006). 
Pharmacological Interventions; One of the methods that is investigated for the prevention 
of neurological dysfunction after CPB, is pharmacological protection, though remains 
controversial. It has been reported that the incidence of neurocognitive dysfunction can be 
lowered by using short-acting anesthetic and analgesic agents, providing a faster recovery 
from general anesthesia (Chen et al,2001). Shorter emergence times can be achieved by using 
low blood-gas partition coefficient and rapidly eliminated volatile anesthetics such as 
sevoflurane and desflurane (Frink et al,1992;Tsai et al,1992). In their preliminary report,  
Kanbak et al. reported that isoflurane and propofol were similar in terms of 
neuropsycological test scores and neurological examination after CPB, despite increased 
levels of S100BP in the propofol group (Kanbak et al,2004). Kanbak et al. also investigated 
the effects of isoflurane, desflurane and sevoflurane on cognitive function after CABG, 
comparing them in terms of neurological tests and S100BP levels. Isoflurane has been 
reported to provide better cognitive outcome (Kanbak et al,2007). 
Pexelizumab, lidocaine, magnesium, ketamine, 17ǃ-estradiol, donepezil, aprotinin are the 
pharmacological agents that are investigated for their efficacy on neurocognitive functions 
after cardiac surgery, however, all require further evaluation. There are no ideal 
pharmacological agent for neuroprotection during cardiac surgery (Lombard et al,2010; 
Grogan et al,2008).  
Recommendations to reduce brain injury during cardiac surgery (Grogan et al,2008) 
 A membrane oxygenator and an arterial line filter (<40µM) should be used for CPB 
(Class I, LOE A) 
 Epiaortic ultrasound for detection of atherosclerosis of the ascending aorta (Class I, LOE 
B) 
 Hyperthermia should be avoided during and after CPB (Class I, LOE B) 
 A single aortic-cross-clamp tecnique should be used for patients at risk for 
atheroembolism (Class IIa, LOE B) 
 During CPB in adults, ǂ-stat pH management should be considered (Class IIa, LOE A) 
 Arterial line temperature during CPB rewarming should be limited to 37 C (Class IIa, 
LOE B) 
 NIRS monitoring should be considered, especially in high-risk patients (Class IIb, LOE 
B) 
 Arterial blood pressure should be maintained At >70 mmHg during CPB in high-risk 
patients (Class IIb, LOE B) 
 Serum glucose should be kept <140 mg/dl with an infusion of insulin (Class IIb, LOE 
C) 
 Transfusion of packed RBC should be considered in high-risk patients when 
hemoglobin is <7 gr/dl or higher depending on other patient-specific considerations 
(Class IIb, LOE C) 
 Processing cardiotomy suction aspirate with a cell-saver device as a means for 
preventing neurocognitive dysfunction (Class indeterminate (LOE A)) 
 There are no pharmacological neuroprotective agents with proven efficacy in humans 
(Class indeterminate (LOE B))  
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4.4 Acute kidney injury (AKI) 
Acute kidney injury known to be an independent predictor of mortality in cardiac surgery, 
has an incidence of 50% by some defnitions, doubling the postoperative and intensive care 
unit costs (Park et al,2010). The pathophysiologic processes of cardiac-surgery associated 
AKI (CSA-AKI) were concluded to be; exogenous and endogeneous toxins, metabolic 
factors, ischemia-reperfusion, neurohormonal activation, inflammation and oxidative stress, 
which are interrelated and probably synergistic (Garwood,2010).  
A common terminology and definition is necessary to determine the high-risk patients for 
the development of CSA-AKI. The term acute renal injury reflects the entire spectrum of the 
disease process; from minimal changes in serum creatinin to anuric renal failure, from 
functional deviations to structural changes and from prerenal azotemia to acute tubular 
necrosis (Dennen et al,2010). The Second International Cosensus Conference of the Acute 
Dialysis Quality Initiative (ADQI) group published a classification system for AKI based on 
the changes in serum creatinin and/or urine output. In this 5-stage classification, first 3 
describes the risk, injury and failure for the severity of the AKI based on the changes in 
serum creatinin, glomerular filtration rate (GFR) and urine output. Last 2 stages describe 
outcome as loss and end-stage kidney disease, making the acronym RIFLE classification 
(Bellomo et al,2004). Acute Kıdney Injury Network (AKIN) proposed a modification to this 
classification and used a time frame of 48 hours in which the AKI has to occur and included 
lesser degrees of serum creatinin elevation. ADQI subdivided this classification into stages 
as early (within the first 7 days) and late (occuring between 7 and 30 days after cardiac 
surgery) (Hoste et al,2008).  
In order to prevent cardiac surgery associated acute kidney injury (CSA-AKI) the most 
important approach is providing adequate renal perfusion throughout the surgery. 
Although there is no guide for any specific fluid or vasoactive agent to improve renal 
function, it is important to identify patients who are at increased risk such as patients in 
volume depletion and have congestive heart failure (Tolwani et al,2008). However it 
should be kept in mind that pathophysiological events other than changes in RBF are also 
responsible for development of AKI (Garwood,2010,as cited in Bonventre et al,2004 & 
Friedewald et al,2004). The patients known to have renal disease are more prone to have 
systemic acidosis and electrolyte disturbances mainly hyperkalemia, requiring more 
frequent blood gas and electrolyte sampling. Intraoperatively adequate fluid and 
medication management should be done for the dialysis patients ensuring that they have 
a recent dialysis with an adequate serum potassium level (London et al,2008). The 
ongoing investigations have a goal to define a single or a panel of early biomarkers to 
prospectively identify the potential for developing AKI after cardiac surgeries 
(Garwood,2010). 
Cardiac surgery patients are particularly at risk of volume-responsive AKI; which is the 
term used more favorably than prerenal azotemia, emphasizing that despite the reversibility 
of early stages of AKI, even minor increases above baseline may result in adverse outcomes 
and any degree of renal insufficiency no matter how small may result in significant clinical 
consequences even in the absence of complete loss of function (Garwood,2010).  
The non-volume responsive AKI also may occur in cardiac surgical patients. Ischemic 
period which has been clearly defined in experimental models, is also clearly defined to 
be associated with multiple injurious events in humans during the perioperative period. 
The key sign is a rapid, progressive and profound decline in GFR, which continue and 
progress even after return of renal perfusion to baseline (Garwood,2010). 
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Pathophysiological events other than changes in RBF are also responsible for the 
development of AKI (Garwood,2010,as cited in Molitoris et al,2004Bonventre et al,2004 & 
Friedewald et al,2004 ). 
As the AKI is a multifactorial adverse consequence, it is crucial to address these 
interreacting factors for the prevention and treatment of CSA-AKI. The disease process 
includes ischemia, endothelial and epithelial dysfunction and tubular injury 
(Garwood,2010). Despite their limitations and variabilities in the AKI definitions and 
targeting mostly the prevention rather than treatment, there are many trials investigating 
the effects of vasodilators-primarily increasing the renal blood flow (dopamine, 
dopexamine, fenoldopam, angiotensin-converting enzyme inhibitors (ACEI) (captopril, 
enalaprilat), diltiazem, prostacyclin, nifedipine, PGE-1, sodium nitroprusside, theophylline), 
interventions inducing natriuresis or diuresis or both (atrial natriuretic peptid, brain 
natriuretic peptid, urodilatin, diuretic agents (loop diuretics and mannitol), anti-
inflammatory agents (N-acetyl cyctein, aspirin, glutathion, corticosteroids, leukodepletion), 
clonidine, albumin infusion, isotonic saline infusion, insulin therapy, early continous veno-
venous hemofiltration and also off vs on-pump technique. Fenoldopam, ACEI, atrial 
natriuretic peptide (nesiritide), B-natriuretic peptid, urodilatin were associated with 
reduction in the incidence of CSA-AKI. Off-pump surgical technique and pulsatile flow 
techniques also were reported to reduce the incidence (Park et al,2010). The recent trials are 
investigating reactive oxygen molecule scavengers, anti-inflammatory agents and 
antiapoptotic agents. AKIN also identifies the antiapoptotic agents (e.g.tetracyclines, human 
recombinant erythropoietin (HrEPO)) as potentially useful for AKI, though further researchs 
are needed (Garwood,2010).   
4.5 Acute lung injury  
Impaired pulmonary function is a well-known complication of cardiac surgeries, however it 
has multiple factors to be related with such as anesthesia, temporary cardiac dysfunction, 
infused catecolamines, altered mechanics of thoracic cage, duration of mechanical 
ventilation, neurological, renal and infectious complications rather than a single factor; CPB 
being the mostly accused. Although it is not possible to perform all the cardiac procedures 
without CPB, avoiding bypass alone cannot prevent the lung injury completely (Apostolakis 
et al,2010). 
Although there are limited, insufficient data supporting the broad clinical use heparin-
coated circuits and miniaturized circuits, minimizing the extracorporeal surface area and 
being biocompatible and free of any material that activates blood should lower the incidence 
of lung injury (de Vroege et al,2004). Leucocyte depletion may reduce the entrapment into 
lung capillaries, that in experimental studies it has been shown to reduce the heart and lung 
reperfusion injury (Apostolakis et al,2010,as cited in Bando et al,1990). Ultrafiltration and 
controlled hemodilution reduce interstitial lung edema, improving the lung functions after 
surgery (Apostolakis et al,2010). Using a controlled cardiac suction device, reducing the time 
between the contact of shed blood with pericardium and its re-transfusion, becoming 
activated only when the blood is accumulated in pericardium-minimizing air entrance may 
also improve  lung functions. Furthermore, since the heparin level of pericardial blood is 
lower than systemic level, topical heparin administration may also diminish the 
inflammatory reactions contributing to lung injury (Tabuchi et al,1993). 
Apnoea during CPB has been shown to be associated with increased incidence of 
pulmonary dysfunction. The results of clinical trials are conflicting, that some revealed 
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improvement in lung functions by maintaining ventilation (with or without CPAP) together 
with pulmonary artery perfusion during CPB, whereas others revealed no difference 
(Stanley et al,1977;John et al,2008).  
The rules of myocardial protection during ischemia and reperfusion, indirectly protect the 
lungs from several proinflammatory factors produced during the process  (Apostolakis et 
al,2010). 
5. Coronary artery bypass grafting without cardiopulmonary bypass 
Cardiopulmonary bypass is still the most common technique used for coronary artery 
bypass grafting procedures. Offpump coronary artery bypass (OPCAB) grafting, being the 
major improvement in cardiac surgeries, is  performed at a rate of 20-30%. Despite the lack 
of definitive literature, its safety and efficacy in providing improvement in several outcomes 
have been proven, especially in high-risk patients with co-morbidities associated with 
higher mortality and morbidity from CPB (e.g. cerebrovascular and renal disease), avoiding 
the adverse effects of cannulation and CPB including hypothermia, risk of rewarming, 
coagulation abnormalities, renal impairment, arrhtyhmias, manipulation and cross-
clamping of the ascending aorta (which increases the risk of aortic dissection/ neurologic 
sequelae) and prolonged postoperative ventilation. These procedures shorten the duration 
of the procedure, lenght of stay in ICU and hospital, and possibly decrease the cost (London 
et al,2008; Barnes, 2002b). 
OP-CAB or minimally invasive direct CAB (MIDCAB) are the alternatives to be used in 
order to avoid CPB. In these settings the anesthetists encounters more surgeon-induced 
hemodynamic changes when it is compared to routine CABG; having a major role for 
anticipating and communicating with the surgeon about the adverse events that occur 
during surgical manipulation. The operation on the beating heart may be more prone to 
develop arrhtyhmias because of ischemia, manipulation and reperfusion. Antiarrhtyhmics, 
asking the surgeon to temporarily stop manipulation and  treating severe bradycardia 
pharmacologically or with epicardial or transvenous pacing are the main strategies. During 
the exposure of the arteries, the heart is lifted and rotated, when the heart is repositioned 
venous return will be compromised leading to a decrease in preload reducing the cardiac 
output. Fluid resuscitation, inotropic medications and peripheral vasoconstrictors may be 
required. Maintenance of adequate coronary perfusion is provided by the maintenance of 
the mean blood pressure close to baseline. In OP-CAB for the proximal anastamoses a side-
biting C-clamp is placed on the aorta providing that the blood pressure is lowered. 
Nitroglycerin and nitroprusside can be used for this purpose (Barnes,2002b). With a skilled 
surgeon, the changes are modest and can be managed by using simply the Trandelenburg 
position, inotropes and vasoconstrictors, however severe changes associated with acute 
ischemia, mitral regurgitation or unrecognized right ventricular compression necessiate 
emergent conversion to CPB (London et al,2008). 
A large bore cannulae should be in place, cross-matched blood should be readily available  
and CPB circuit should be set up with a perfusionist on standby. In MIDCAB method, since 
the access to the heart is limited, external defibrillator and pacing pads should be ready 
during the operation (Barnes,2002b). Although there is no definitive type of monitoring 
described, most observational studies have used extensive monitoring including PAC and 
TEE. However, as the practice improves, particularly for the low-risk patients the 
recommended type of monitoring will probably become less sofisticated (London et al,2008). 
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